CC chemokine receptor 5 and renal-transplant survival

Lancet

Volumn 357, Issue 9270, 2001, Pages 1758-1761

  Fischereder, Michael ^a,e   Luckow, Bruno ^a   Hocher, Berthold ^b   Wüthrich, Rudolf P ^c   Rothenpieler, Uwe ^a   Schneeberger, Helmut ^a   Panzer, Ulf ^d   Stahl, Rolf A K ^d   Hauser, Ingeborg A ^f,g   Budde, Klemens ^b   Neumayer, Hans H ^b   Krämer, Bernhard K ^e   Land, Walter ^a   Schlöndorff, Detlef ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOME; GENOTYPE; GRAFT SURVIVAL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY GRAFT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RECIPIENT;

EID: 0035796003     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04898-4     Document Type: Article

References (29)

1. Searching for genetic determinants in the new millennium
2. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
3. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
4. Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsy sections: Analysis by scanning laser confocal microscopy
5. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
6. Acute cellular rejection of human renal tissue by adoptive transfer of allogeneic human peripheral blood mononuclear cells into chimeric rats: Sequential gene expression of cytokines, chemokines and cytolytic effector molecules, and their regulation by CTLA-4-Ig
7. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
8. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha
9. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES
10. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication
11. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
12. International union of pharmacology. XXII. Nomenclature for chemokine receptors
13. The biology of chemokines and their receptors
14. Chemokines and leukocyte traffic
15. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
16. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
17. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
18. Global distribution of the CCR5 gene 32-basepair deletion
19. The deltaCCr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe
20. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes
21. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
22. Association of CCR5 delta32 with reduced risk of asthma
23. Early loss of renal transplants in patients with thrombophilia
24. High rate of acute rejections in renal allograft recipients with thrombophilic risk factors
25. Expression of the C-C chemokine receptor 5 in human kidney diseases
26. The role of the CC chemokine, RANTES, in acute lung allograft rejection
27. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
28. CC chemokine receptor 5 polymorphism in rheumatoid arthritis
29. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis